Join to View Full Profile
Women's Malignancies Branch, National Cancer Institute, NIHBuilding 10, Room 4B54, 10 Center DriveBethesda, MD 20892
Phone+1 240-760-6129
Fax+1 240-541-4547
Dr. Lipkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1984 - 1987
Weill Cornell MedicineClass of 1984
Certifications & Licensure
MD State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition.David J Wisniewski, Donna Voeller, Yonit A Addissie, Sachin Kumar Deshmukh, Sharon Wu
Oncogene. 2025-11-25 - Chronic inflammatory diseases and survival among breast cancer patients in the U.S. military health system.Jie Lin, Stanley Lipkowitz, Hai Hu, Matthew Nealeigh, Craig D Shriver
Breast Cancer Research and Treatment. 2025-11-21 - Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancer.Jung-Min Lee, Junya Tabata, Tzu-Ting Huang, Elena Giudice, Kristen Ibanez
Research Square. 2025-10-05
Press Mentions
Behind the Study: How ONC201 Kills Breast Cancer CellsApril 22nd, 2022- Panel Tells FDA to Keep Atezolizumab Approval in TNBCApril 28th, 2021
ONC201 Kills Breast Cancer Cells in Vitro by Targeting MitochondriaMay 9th, 2018- Join now to see all
Grant Support
- Identification Of Molecular Targets In Triple-Negative Breast CancerDivision Of Basic Sciences - Nci2009
- Trail-Induced Cell Death In Breast Cancer CellsNational Cancer Institute2008
- Identification Of Molecular Targets In Triple-Negative Breast CancerNational Cancer Institute2008
- Signal Transduction In Epithelial Cancer CellsNational Cancer Institute2007
- Signal Transduction In Epithelial Cancer CellsDivision Of Clinical Sciences - Nci2006
- Molecular Control Of Growth, Differentiation, And DeathDivision Of Clinical Sciences - Nci2001–2005
- Molecular Control Of Growth, Differentiation, And Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci1999–2000
- Molecular Control Of Growth, Differentiation And Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci1996–1998
- Genomic characterization of breast cancer in high risk subsets of breast cancerDIVISION OF BASIC SCIENCES - NCIPresent
- Activating Cell Death Pathways in Breast Cancer CellsDIVISION OF CLINICAL SCIENCES - NCIPresent
- Cbl Proteins as Regulators of Tyrosine Kinase SignalingDIVISION OF BASIC SCIENCES - NCIPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
